Literature DB >> 12917394

Rac2 specificity in macrophage integrin signaling: potential role for Syk kinase.

De Pradip1, Xiaodong Peng, Donald L Durden.   

Abstract

Herein we report that, despite the similarity of Rac2 to Rac1 (92% amino acid identity), macrophages derived from Rac2-/- mice, which continue to express Rac1, display a marked defect in alphavbeta3/alphavbeta5 and alpha4beta1 integrin-directed migration measured on vitronectin and fibronectin fragments (FN-H296), respectively. In contrast, mouse embryo fibroblasts derived from the Rac2 knockout mice utilize Rac1 for migration via alphavbeta3/alphavbeta5 and alpha4beta1. The genetic reconstitution of bone marrow-derived macrophages (BMM) with Rac2 restores the integrin-dependent migration of Rac2-deficient macrophages on vitronectin (VN) and FN-H296. The levels of GTP-Rac2 generated upon specific integrin engagement in wild type macrophages parallels the phenotypic defect observed in Rac2-deficient macrophages; i.e. FN-H296, alpha4beta1 > VN, alphavbeta3/alphavbeta5 > FN-CH271, alpha5beta1 > intact FN. In a COS7 cell system, the expression of Syk kinase alone is sufficient to convert the alpha4beta1 migration response to Rac2 dependence. Therefore, we present the first evidence that the alpha4beta1 receptor in blood cells has evolved a Syk-Rac2 signaling axis to transmit signals required for integrin-directed migration suggesting that Syk kinase in part encodes myeloid Rac2 specificity in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917394     DOI: 10.1074/jbc.M306491200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  ROCK1 functions as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability.

Authors:  Sasidhar Vemula; Jianjian Shi; Philip Hanneman; Lei Wei; Reuben Kapur
Journal:  Blood       Date:  2009-12-11       Impact factor: 22.113

2.  Genetic deletion of the Rho GEF Net1 impairs mouse macrophage motility and actin cytoskeletal organization.

Authors:  Yan Zuo; John d'Aigle; Anjali Chauhan; Jeffrey A Frost
Journal:  Small GTPases       Date:  2017-12-31

3.  p85alpha subunit of class IA PI-3 kinase is crucial for macrophage growth and migration.

Authors:  Veerendra Munugalavadla; Jovencio Borneo; David A Ingram; Reuben Kapur
Journal:  Blood       Date:  2005-03-15       Impact factor: 22.113

4.  Osteoclasts lacking Rac2 have defective chemotaxis and resorptive activity.

Authors:  Takashi Itokowa; Mei-ling Zhu; Nancy Troiano; Jessica Bian; Tustomu Kawano; Karl Insogna
Journal:  Calcif Tissue Int       Date:  2010-11-26       Impact factor: 4.333

5.  Rac2 Functions in Both Neutrophils and Macrophages To Mediate Motility and Host Defense in Larval Zebrafish.

Authors:  Emily E Rosowski; Qing Deng; Nancy P Keller; Anna Huttenlocher
Journal:  J Immunol       Date:  2016-11-11       Impact factor: 5.422

6.  Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules.

Authors:  De Pradip; Mark Bouzyk; Nandini Dey; Brian Leyland-Jones
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

7.  Anti-tumor efficacy of BEZ235 is complemented by its anti-angiogenic effects via downregulation of PI3K-mTOR-HIF1alpha signaling in HER2-defined breast cancers.

Authors:  Nandini Dey; Yuliang Sun; Jennifer H Carlson; Hui Wu; Xiaoqian Lin; Brian Leyland-Jones; Pradip De
Journal:  Am J Cancer Res       Date:  2016-03-15       Impact factor: 6.166

8.  Expression of RAC2 in endothelial cells is required for the postnatal neovascular response.

Authors:  Pradip De; Qiong Peng; Dmitry O Traktuev; Dmitry O Traktuevc; Weiming Li; Mervin C Yoder; Keith L March; Donald L Durden
Journal:  Exp Cell Res       Date:  2009-01-15       Impact factor: 3.905

9.  Macrophage Syk-PI3Kγ Inhibits Antitumor Immunity: SRX3207, a Novel Dual Syk-PI3K Inhibitory Chemotype Relieves Tumor Immunosuppression.

Authors:  Shweta Joshi; Donald L Durden; Kevin X Liu; Muamera Zulcic; Alok R Singh; Dylan Skola; Christopher K Glass; P Dominick Sanders; Andrew B Sharabi; Timothy V Pham; Pablo Tamayo; Daniel Shiang; Huy Q Dinh; Catherine C Hedrick; Guillermo A Morales; Joseph R Garlich
Journal:  Mol Cancer Ther       Date:  2020-01-23       Impact factor: 6.261

10.  PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells.

Authors:  Hal E Crosswell; Anindya Dasgupta; Carlos S Alvarado; Tanya Watt; James G Christensen; Pradip De; Donald L Durden; Harry W Findley
Journal:  BMC Cancer       Date:  2009-11-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.